LivaNova Prices $300M Convertible Senior Notes Offering
LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, has announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (referred…